Cargando…

Investigation of expression of 5T4 antigen in cervical cancer.

A monoclonal antibody detecting amniotrophoblastic antigen 5T4 has shown reactivity against various neoplastic cell lines and tumour specimens but with a relatively restricted normal tissue expression. This antibody has been investigated as a potential indicator of premalignant changes identified as...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, H., Roberts, G., Hole, N., McDicken, I. W., Stern, P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971310/
https://www.ncbi.nlm.nih.gov/pubmed/2404512
_version_ 1782134882705604608
author Jones, H.
Roberts, G.
Hole, N.
McDicken, I. W.
Stern, P.
author_facet Jones, H.
Roberts, G.
Hole, N.
McDicken, I. W.
Stern, P.
author_sort Jones, H.
collection PubMed
description A monoclonal antibody detecting amniotrophoblastic antigen 5T4 has shown reactivity against various neoplastic cell lines and tumour specimens but with a relatively restricted normal tissue expression. This antibody has been investigated as a potential indicator of premalignant changes identified as cervical intra-epithelial neoplasia and malignant cervical lesions using immunohistochemistry on frozen tissue biopsies. The basal cells of normal cervical stratified epithelium exhibited faint staining, but a general increase in intensity and extent of specific labeling of this tissue was seen from the first premalignant stage through to carcinoma. In most cases, this was in accordance with the distribution of dysplastic cells, and was accompanied by increased specific staining of the stromal tissue. All invasive squamous carcinomas of the cervix were 5T4 antigen positive. Common inflammatory non-malignant diseases did show a certain degree of epithelial and stromal reactivity. These results, showing 5T4 reactivity with neoplastic and pre-neoplastic lesions, may provide a quantitative basis for its potential use as a tumour marker in the immunochemical detection on immunoassay of cervical cancer. IMAGES:
format Text
id pubmed-1971310
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19713102009-09-10 Investigation of expression of 5T4 antigen in cervical cancer. Jones, H. Roberts, G. Hole, N. McDicken, I. W. Stern, P. Br J Cancer Research Article A monoclonal antibody detecting amniotrophoblastic antigen 5T4 has shown reactivity against various neoplastic cell lines and tumour specimens but with a relatively restricted normal tissue expression. This antibody has been investigated as a potential indicator of premalignant changes identified as cervical intra-epithelial neoplasia and malignant cervical lesions using immunohistochemistry on frozen tissue biopsies. The basal cells of normal cervical stratified epithelium exhibited faint staining, but a general increase in intensity and extent of specific labeling of this tissue was seen from the first premalignant stage through to carcinoma. In most cases, this was in accordance with the distribution of dysplastic cells, and was accompanied by increased specific staining of the stromal tissue. All invasive squamous carcinomas of the cervix were 5T4 antigen positive. Common inflammatory non-malignant diseases did show a certain degree of epithelial and stromal reactivity. These results, showing 5T4 reactivity with neoplastic and pre-neoplastic lesions, may provide a quantitative basis for its potential use as a tumour marker in the immunochemical detection on immunoassay of cervical cancer. IMAGES: Nature Publishing Group 1990-01 /pmc/articles/PMC1971310/ /pubmed/2404512 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Jones, H.
Roberts, G.
Hole, N.
McDicken, I. W.
Stern, P.
Investigation of expression of 5T4 antigen in cervical cancer.
title Investigation of expression of 5T4 antigen in cervical cancer.
title_full Investigation of expression of 5T4 antigen in cervical cancer.
title_fullStr Investigation of expression of 5T4 antigen in cervical cancer.
title_full_unstemmed Investigation of expression of 5T4 antigen in cervical cancer.
title_short Investigation of expression of 5T4 antigen in cervical cancer.
title_sort investigation of expression of 5t4 antigen in cervical cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971310/
https://www.ncbi.nlm.nih.gov/pubmed/2404512
work_keys_str_mv AT jonesh investigationofexpressionof5t4antigenincervicalcancer
AT robertsg investigationofexpressionof5t4antigenincervicalcancer
AT holen investigationofexpressionof5t4antigenincervicalcancer
AT mcdickeniw investigationofexpressionof5t4antigenincervicalcancer
AT sternp investigationofexpressionof5t4antigenincervicalcancer